Reshape Lifesciences Inc. (HIND) — S-1/A Filings
All S-1/A filings from Reshape Lifesciences Inc.. Browse 5 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (5)
-
ReShape Lifesciences Files S-1/A Amendment
— Feb 14, 2025 Risk: medium
ReShape Lifesciences Inc. filed an S-1/A amendment on February 14, 2025, for its registration statement (No. 333-284362). The company, formerly known as Obalon -
ReShape Lifesciences Files S-1/A Amendment
— Feb 13, 2025 Risk: medium
ReShape Lifesciences Inc. filed an S-1/A amendment on February 13, 2025, for its registration statement (No. 333-284362). The company, formerly known as Obalon -
ReShape Lifesciences Files S-1/A Update
— Feb 7, 2025 Risk: medium
ReShape Lifesciences Inc. filed an S-1/A on February 7, 2025, to update its registration statement. The company, formerly Obalon Therapeutics Inc., is incorpora -
ReShape Lifesciences Files S-1/A Update
— Feb 6, 2025 Risk: medium
ReShape Lifesciences Inc. filed an S-1/A on February 6, 2025, to update its registration statement. The company, formerly Obalon Therapeutics Inc., is based in -
ReShape Lifesciences Files S-1/A Amendment
— Jan 15, 2025 Risk: medium
ReShape Lifesciences Inc. filed an S-1/A amendment on January 15, 2025, for its registration statement (No. 333-283952). The company, formerly Obalon Therapeuti
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX